NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
1.05
Dollar change
+0.01
Percentage change
0.96
%
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand4.53M Perf Week0.48%
Market Cap13.88M Forward P/E- EPS next Y-0.03 Insider Trans- Shs Float4.08M Perf Month-2.78%
Enterprise Value- PEG- EPS next Q-0.11 Inst Own0.99% Short Float0.72% Perf Quarter-29.00%
Income- P/S- EPS this Y15.09% Inst Trans162.45% Short Ratio0.14 Perf Half Y-26.57%
Sales- P/B- EPS next Y93.33% ROA- Short Interest0.03M Perf YTD-35.38%
Book/sh- P/C- EPS next 5Y- ROE- 52W High4.69 -77.61% Perf Year-60.38%
Cash/sh- P/FCF- EPS past 3/5Y49.12% 52.35% ROIC- 52W Low0.98 7.14% Perf 3Y-88.20%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-7.55% -19.81% Gross Margin- Volatility3.86% 3.65% Perf 5Y-94.10%
Dividend TTM- EV/Sales- EPS Y/Y TTM50.36% Oper. Margin- ATR (14)0.05 Perf 10Y-99.70%
Dividend Ex-Date- Quick Ratio- Sales Y/Y TTM- Profit Margin- RSI (14)44.41 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio- EPS Q/Q67.30% SMA20-2.48% Beta1.11 Target Price7.25
Payout- Debt/Eq- Sales Q/Q-21.32% SMA50-3.66% Rel Volume1.06 Prev Close1.04
Employees5 LT Debt/Eq- EarningsMay 22 SMA200-35.73% Avg Volume210.44K Price1.05
IPONov 01, 2012 Option/ShortNo / Yes EPS/Sales Surpr.0.00% - Trades Volume223,001 Change0.96%
Date Action Analyst Rating Change Price Target Change
Aug-11-17Initiated Maxim Group Buy $7
Oct-19-16Resumed ROTH Capital Buy
Aug-29-16Resumed Rodman & Renshaw Buy $6
Nov-30-15Reiterated H.C. Wainwright Buy $4 → $6
Mar-31-15Reiterated H.C. Wainwright Buy $7 → $3
Mar-30-15Downgrade ROTH Capital Buy → Neutral $20 → $2.40
Dec-29-14Reiterated ROTH Capital Buy $28 → $20
Nov-18-14Initiated H.C. Wainwright Buy $7
Jun-16-25 09:00AM
May-05-25 08:00AM
Apr-17-25 08:55AM
Apr-14-25 02:28PM
08:30AM
08:00AM Loading…
08:00AM
Mar-24-25 09:00AM
Mar-20-25 09:45AM
Mar-19-25 09:00AM
Mar-18-25 08:30AM
Mar-03-25 06:00AM
Feb-18-25 07:00AM
Feb-10-25 07:10AM
Feb-05-25 07:00AM
Jan-28-25 10:30AM
07:00AM Loading…
Jan-27-25 07:00AM
Jan-09-25 12:00PM
Dec-30-24 07:00AM
Dec-09-24 09:55AM
Dec-04-24 07:00AM
Nov-22-24 09:00AM
Nov-11-24 07:00AM
Nov-05-24 07:28AM
Nov-04-24 07:08AM
Oct-18-24 09:06AM
Oct-09-24 07:00AM
Oct-07-24 07:00AM
Sep-24-24 07:00AM
Sep-16-24 07:00AM
Aug-30-24 09:48AM
08:15AM Loading…
Aug-29-24 08:15AM
Aug-09-24 09:00AM
Aug-08-24 07:01PM
Jul-29-24 07:00AM
Jul-17-24 07:00AM
Jul-11-24 07:00AM
Jul-01-24 07:00AM
Jun-28-24 07:00AM
Jun-24-24 07:00AM
Jun-10-24 07:00AM
Jun-05-24 07:00AM
May-29-24 07:00AM
May-27-24 07:00AM
May-23-24 07:00AM
May-13-24 07:00AM
May-10-24 09:00AM
06:23AM
May-09-24 07:00AM
May-06-24 07:00AM
Apr-29-24 09:00AM
Apr-25-24 07:00AM
Apr-15-24 07:00AM
Apr-03-24 07:00AM
Apr-01-24 07:00AM
Mar-28-24 07:00AM
Mar-11-24 07:00AM
Feb-28-24 07:00AM
Jan-30-24 07:00AM
Jan-29-24 07:00AM
Dec-20-23 07:00AM
Dec-18-23 07:00AM
Dec-04-23 07:00AM
Nov-30-23 07:00AM
Nov-22-23 07:23AM
Nov-21-23 01:53PM
07:00AM
Nov-01-23 07:00AM
Oct-30-23 09:55AM
07:00AM
Oct-27-23 10:00AM
06:07AM
Oct-26-23 07:00AM
Oct-09-23 07:00AM
Sep-27-23 07:00AM
Sep-07-23 07:00AM
Aug-31-23 07:00AM
Aug-24-23 07:10AM
Aug-18-23 07:00AM
Aug-08-23 07:00AM
Jul-17-23 07:00AM
Jul-11-23 07:00AM
Jul-07-23 07:00AM
Jun-29-23 07:00AM
Jun-14-23 12:17PM
Jun-13-23 07:00AM
Jun-02-23 07:00AM
Jun-01-23 07:00AM
May-30-23 07:00AM
May-15-23 07:00AM
May-10-23 12:00PM
May-09-23 07:00AM
May-02-23 07:00AM
Apr-24-23 07:00AM
Apr-10-23 07:00AM
Mar-30-23 07:15AM
Mar-16-23 07:00AM
Mar-13-23 07:00AM
Feb-14-23 07:00AM
Jan-24-23 07:00AM
Jan-11-23 09:04AM
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.